Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LOC101927086 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
PJA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ADARB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
PTN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CTTNBP2NL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANKH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
INTU - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF32-AS3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DIRC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SCAMP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAFK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM208A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GRK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WHSC1L1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ERICH1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LZTS1-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on